AstraZeneca advice unlikely to change despite rate of rare clotting ‘doubling’ – Sydney Morning Herald

Professor Cheng said incidence of cases reported from Europe was still a pretty small number and possibly a result of doctors getting better at detecting the condition, which has a fatality rate of about one in four cases.
Im sure very early on, before anyone realised what this was, people thought it was just an unusual clot there may have been some that flew under the radar, he said.
ATAGI issued an advisory in early April recommending people under 50 receive the Pfizer vaccine ahead of the AstraZeneca…

Click here to view the original article.